98 related articles for article (PubMed ID: 430485)
21. Stereoselective effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) on schedule-controlled behavior.
Harris RA; Snell D; Loh HH
Pharmacol Biochem Behav; 1977 Oct; 7(4):307-10. PubMed ID: 928488
[TBL] [Abstract][Full Text] [Related]
22. Sulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)-and (2,5-dimethoxy-4-ethylphenyl)isopropylamine.
Jacob P; Shulgin AT
J Med Chem; 1983 May; 26(5):746-52. PubMed ID: 6842515
[TBL] [Abstract][Full Text] [Related]
23. Stereospecific actions of 2,5-dimethoxy-4-methylamphetamine (DOM) on colonic temperature in the rat at various ambient temperatures.
Beaton JM; Benington F; Bradley RJ; Kuhlemeier KV; Morin RD
Br J Pharmacol; 1976 Aug; 57(4):547-50. PubMed ID: 134754
[TBL] [Abstract][Full Text] [Related]
24. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
[No Abstract] [Full Text] [Related]
25. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.
Benneyworth MA; Smith RL; Sanders-Bush E
Neuropsychopharmacology; 2008 Aug; 33(9):2206-16. PubMed ID: 17957214
[TBL] [Abstract][Full Text] [Related]
26. N-Hydroxylation of 1-(2,5-demethoxy-4-methylphenyl)-2-aminopropane by rabbit liver microsomes.
Gal J; Gruenke LD; Castagnoli N
J Med Chem; 1975 Jul; 18(7):683-8. PubMed ID: 1151987
[TBL] [Abstract][Full Text] [Related]
27. In vitro O-demethylation of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Zweig JS; Castagnoli N
J Med Chem; 1977 Mar; 20(3):414-21. PubMed ID: 845874
[TBL] [Abstract][Full Text] [Related]
28. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
[TBL] [Abstract][Full Text] [Related]
29. A reevaluation of psychotomimetic amphetamine derivatives in humans.
Cassels BK; Gómez-Jeria JS
J Psychoactive Drugs; 1985; 17(2):129-30. PubMed ID: 4020537
[No Abstract] [Full Text] [Related]
30. Comparative effects of stereoisomers of psychotomimetic phenylisopropylamines.
Dyer DC; Nichols DE; Rusterholz DB; Barfknecht CF
Life Sci; 1973 Oct; 13(7):885-96. PubMed ID: 4766265
[No Abstract] [Full Text] [Related]
31. ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT2a and 5-HT2c receptor agonist.
Acuña-Castillo C; Scorza C; Reyes-Parada M; Cassels BK; Huidobro-Toro JP
Life Sci; 2000 Nov; 67(26):3241-7. PubMed ID: 11191631
[TBL] [Abstract][Full Text] [Related]
32. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
[TBL] [Abstract][Full Text] [Related]
33. Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors.
Ponzoni L; Braida D; Sala M
Psychopharmacology (Berl); 2016 Aug; 233(15-16):3031-9. PubMed ID: 27318987
[TBL] [Abstract][Full Text] [Related]
34. Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes.
Standridge RT; Howell HG; Tilson HA; Chamberlain JH; Holava HM; Gylys JA; Partyka RA; Shulgin AT
J Med Chem; 1980 Feb; 23(2):154-62. PubMed ID: 7359529
[TBL] [Abstract][Full Text] [Related]
35. Bromo-DMA: the Australasian hallucinogen?
Buhrich N; Morris G; Cook G
Aust N Z J Psychiatry; 1983 Sep; 17(3):275-9. PubMed ID: 6580896
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the effects of R-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM), r-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) and 5-hydroxytryptamine on non-innervated vascular smooth muscle.
Dyer DC
Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):449-54. PubMed ID: 959651
[TBL] [Abstract][Full Text] [Related]
37. Electrochemical study of the hallucinogen (+-)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane.
Richter P; Morales A; Gómez-Jeria JS; Morales-Lagos D
Analyst; 1988 Jun; 113(6):859-63. PubMed ID: 3218759
[No Abstract] [Full Text] [Related]
38. A behavioral comparison of Nexus, cathinone, BDB, and MDA.
Bronson ME; Jiang W; DeRuiter J; Clark CR
Pharmacol Biochem Behav; 1995; 51(2-3):473-5. PubMed ID: 7667371
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of substituted-amphetamine hallucinogens using the cat limb flick model.
Rusterholz DB; Spratt JL; Long JP; Barfknecht CF
Commun Psychopharmacol; 1977; 1(6):589-92. PubMed ID: 608329
[No Abstract] [Full Text] [Related]
40. Asymmetric synthesis of psychotomimetic phenylisopropylamines.
Nichols DE; Barfknecht CF; Rusterholz DB; Benington F; Morin RD
J Med Chem; 1973 May; 16(5):480-3. PubMed ID: 4718460
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
